Regulation of human cancer by cytokines : present status and future prospects
Author(s)
Bibliographic Information
Regulation of human cancer by cytokines : present status and future prospects
(Gann monograph on cancer research / Japanese Cancer Association, no. 40)
Japan Scientific Societies Press , CRC Press, 1993
- : ja
- : us
Available at 15 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and indexes
Description and Table of Contents
Description
This book considers clinical problems associated with new modalities of cancer treatment involving recombinant cytokines. The first half of the book is devoted to various types of associations of cytokines with tumor cells, while the second half addresses the therapeutic potential of multidisciplinary devices in biological treatment with recombinant cytokine. Some of these indicate the future direction of cancer treatment.
Table of Contents
Overview: Cancer Control by Cytokines (Y. Hashimoto). Roles of Cytokines in Human Neoplastic Cell Growth: Role of Interleukin 6 in Pathogenesis of B Lymphocyte-Proliferative Diseases (K. Yoshizaki, N. Nishimoto, K. Kondo, H. Tagoh, and T. Kuritani). Involvement of IL-6 in Development of Myeloma (M. Kawano and O. Tanabe). Roles of IL-6 and NF-IL6 in AIDS Kaposi Sarcoma (H. Isshiki, S. Akira, and T. Kishimoto). Alterations in Cell Growth Regulatory System by Transforming Growth Factor-ss in Human Hepatocellular Carcinoma (S. Kawata, S. Tamura, N. Ito, K. Takaishi, and Y. Matsuzawa). Growth Inhibitory Activity of Interleukin-3 on Human Nonhematopoietic Tumor Cell Lines (K. Miyagawa, F. Taketazu, C. Misawa, T. Kuwaki, K. Miyazono, and F. Takaku). Autocrine Growth of Leukemia Cells Producing Cytokines (N. Nara). Antitumor Effector Mechanism and Its Potentiation by Cytokines: In Vitro and In Vivo Antitumor Activities of Monocytes Potentiated by Macrophage Colony-Stimulating Factor (M-CSF) (K. Motoyoshi, M. Douzono, T. Sakurai, and N. Yanai). Induction of Interleukin 2-Activated Killer Effector Activity and Its Regulatory Mechanism (S. Sone, A. Nii, and T. Ogura). Bispecific Antibody as a Potentiator of Tumor Cell Killing by IL-2-Activated Lymphocytes (H. Yagita, M. Ikeda, T. Nitta, K. Sato, K. Okumura, and S. Ishii). Role of Tumor-Associated Antigens in Induction of Specific Killing by Cytotoxic T Lymphocytes in Human Autologous Cancers (N. Sato, Y. Wada, H. Ikeda, S. Takahashi, N. Tsuboi, A. Kishi, K. Hirata, and K. Kikuchi). Human Tumor-Infiltrating Lymphocytes (K. Itoh, C.M. Balch, A.C. von Eschenbach, T. Morita, K. Hayakawa, and D. Seito). Interleukin-2 Receptor-Targeted Therapy of ATL (T. Uchiyama, A. Kondo, T. Kiyokawa, K. Yamaguchi, J.R. Murphy, and K. Takatsuki). Antitumor Properties and Possible Application for Gene Therapy with IL-2 Activated Killer Cells (Y. Kohgo, Y. Itoh, N. Watanabe, X. Liu, Y. Koshida, H. Neda, T. Himeno, M. Takahashi, and Y. Niitsu). Clinical and Biological Aspects of Interferon-a in the Treatment of Chronic Myelogenous Leukemia (K. Tani, H. Ogura, T. Inoue, A. Tojo, K. Ozawa, and S. Asano). Future Prospect (F. Takaku). Subject Index. Author Index.
by "Nielsen BookData"